Home > Cashflow Statement > GLAXOSMITHKLINE PHARMACEUTICALS

GLAXOSMITHKLINE PHARMACEUTICALS
Cash Flow from Investing Activities

    Back to Cashflow Statement
GLAXOSMITHKLINE PHARMACEUTICALS is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Best Quarterly Growth Mid Cap Stocks
AD     Remove this Ad

GLAXOSMITHKLINE PHARMACEUTICALS Last 5 Year Cash Flow from Investing Activities History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Cash Flow from Investing Activities ₹-46 Cr₹8.71 Cr₹808 Cr₹-406 Cr₹418 Cr

What is the latest Cash Flow from Investing Activities ratio of GLAXOSMITHKLINE PHARMACEUTICALS ?

The latest Cash Flow from Investing Activities ratio of GLAXOSMITHKLINE PHARMACEUTICALS is ₹-46 Cr based on Mar2025 Consolidated results.
Year Cash Flow from Investing Activities
Mar2025₹-46 Cr
Mar2024₹8.71 Cr
Mar2023₹808 Cr
Mar2022₹-406 Cr
Mar2021₹418 Cr

How is Cash Flow from Investing Activities of GLAXOSMITHKLINE PHARMACEUTICALS Trending?

Years Cash Flow from Investing Activities % Change
Mar2025 ₹-46 Cr
Negative
Mar2024 ₹8.71 Cr
-98.92
Mar2023 ₹808 Cr
Positive
Mar2022 ₹-406 Cr
Negative
Mar2021 ₹418 Cr -

Compare Cash Flow from Investing Activities of peers of GLAXOSMITHKLINE PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLAXOSMITHKLINE PHARMACEUTICALS ₹40,761.9 Cr 2.2% -3.2% -6.5% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹407,083.0 Cr -1% -7% -1% Stock Analytics
DIVIS LABORATORIES ₹163,971.0 Cr 5% -2.7% 15.4% Stock Analytics
TORRENT PHARMACEUTICALS ₹140,660.0 Cr 3.2% -6.2% 29.3% Stock Analytics
DR REDDYS LABORATORIES ₹101,686.0 Cr 2.3% -8.1% 13.5% Stock Analytics
CIPLA ₹99,086.7 Cr 0.9% -7.8% -12.5% Stock Analytics


GLAXOSMITHKLINE PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
GLAXOSMITHKLINE PHARMACEUTICALS

2.2%

-3.2%

-6.5%

SENSEX

4.7%

-0.1%

3.6%


You may also like the below Video Courses